Oramed to Present at H.C. Wainwright Global Life Sciences Conference 2021
NEW YORK, March 4, 2021 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that CEO Nadav Kidron will present a company overview at the H.C. Wainwright Global Life Sciences Conference, held virtually on March 9 – 10, 2021. […]
